The New York State Senate passed legislation to reduce the cost of prescription drugs and treatment for patients in New York State. The proposed legislation includes measures to cap the cost of insulin to $30; permit out-of-state prescription drug shipments in times of need; increase seniors’ access to prescription drugs; require notifications of drug cost increases to patients; and the creation of a wholesale drug importation program. These provisions make significant progress in improving the cost and accessibility of crucial treatments and will inevitably save New York lives.
Senate Majority Leader Andrea Stewart-Cousins said, “The average cost of living for New York families continues to bind households, where hard choices between paying the utility bill or covering the cost of insulin are made every day. These packages of legislation will help ease these burdens by lowering the cost of various prescription drugs, optimizing market prices, cutting away unnecessary red tape, and streamlining services for the middle and working class. I am proud to lead our conference in tackling these pressing issues facing New York State, and I thank the sponsors for advancing this timely and crucial legislation.”